Clinical trial
Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2): a Multi-center, Non-inferiority, Prospective Randomized Controlled Trial
NCT05967507 is registered in ClinicalTrials.gov with Thomas Riva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2): a Multi-center, Non-inferiority, Prospective Randomized Controlled Trial
- Lead sponsor
- Thomas Riva
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 1, 2023
- Completion date
- September 30, 2027
- Enrollment
- 1,192 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
airway management